Citigroup Maintains Buy on Privia Health Gr, Lowers Price Target to $32
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Citigroup analyst Daniel Grosslight maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $34 to $32.
Citigroup analyst Daniel Grosslight maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $34 to $32.